Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+15.42%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$52.9B
AUM Growth
+$52.9B
(+9.6%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
978
New
135
Increased
353
Reduced
289
Closed
117
Top Buys
| 1 |
CSX Corp
CSX
|
$218M |
| 2 |
Merck
MRK
|
$195M |
| 3 |
HES
Hess
HES
|
$171M |
| 4 |
Walmart
WMT
|
$138M |
| 5 |
Lockheed Martin
LMT
|
$102M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
$231M |
| 2 |
Amgen
AMGN
|
$159M |
| 3 |
Honeywell
HON
|
$124M |
| 4 |
Domino's
DPZ
|
$124M |
| 5 |
Dover
DOV
|
$118M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 17.14% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
United Rentals
URI
$61.4B
| $3.74M | 0.01% |
+5,182
| New | +$3.74M |
|
727
Capital One
COF
$142B
| $3.7M | 0.01% |
24,834
-345,040
| -93% | -$51.4M |
|
728
Fox Class B
FOX
$24.7B
| $3.67M | 0.01% |
128,165
| – | – |
|
|
NVEI
729
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $3.64M | 0.01% |
115,000
-200,708
| -64% | -$6.35M |
|
730
Arq
ARQ
$315M
| $3.63M | 0.01% |
560,000
-165,000
| -23% | -$1.07M |
|
731
Rocket Pharmaceuticals
RCKT
$351M
| $3.5M | 0.01% |
130,000
-10,000
| -7% | -$269K |
|
732
Skyworks Solutions
SWKS
$10.8B
| $3.48M | 0.01% |
+32,150
| New | +$3.48M |
|
733
Regenxbio
RGNX
$464M
| $3.48M | 0.01% |
+165,073
| New | +$3.48M |
|
734
Ocular Therapeutix
OCUL
$2.17B
| $3.41M | 0.01% |
+375,000
| New | +$3.41M |
|
735
NextDecade
NEXT
$2.8B
| $3.41M | 0.01% |
+600,000
| New | +$3.41M |
|
736
Hudson Technologies
HDSN
$450M
| $3.34M | 0.01% |
+303,407
| New | +$3.34M |
|
737
Rexford Industrial Realty
REXR
$9.52B
| $3.27M | 0.01% |
65,000
-120,000
| -65% | -$6.04M |
|
738
Immunovant
IMVT
$2.62B
| $3.23M | 0.01% |
100,000
-1,231,780
| -92% | -$39.8M |
|
739
Freshworks
FRSH
$3.81B
| $3.19M | 0.01% |
+175,000
| New | +$3.19M |
|
740
A.O. Smith
AOS
$9.86B
| $3.18M | 0.01% |
35,492
-83,800
| -70% | -$7.5M |
|
741
Symbotic
SYM
$5.07B
| $3.12M | 0.01% |
69,408
+29,408
| +74% | +$1.32M |
|
742
Kimbell Royalty Partners
KRP
$1.3B
| $3.1M | 0.01% |
200,000
-40,000
| -17% | -$621K |
|
743
DT Midstream
DTM
$10.4B
| $3.06M | 0.01% |
50,000
| – | – |
|
744
NET Power
NPWR
$185M
| $3.02M | 0.01% |
265,000
-428,148
| -62% | -$4.88M |
|
745
News Corp Class B
NWS
$18.7B
| $3.02M | 0.01% |
111,534
| – | – |
|
746
Cactus
WHD
$2.83B
| $3.01M | 0.01% |
60,000
| – | – |
|
747
Annovis Bio
ANVS
$44.8M
| $2.98M | 0.01% |
250,000
-35,347
| -12% | -$421K |
|
748
iRhythm Technologies
IRTC
$5.45B
| $2.9M | 0.01% |
+25,000
| New | +$2.9M |
|
749
PotlatchDeltic
PCH
$3.15B
| $2.82M | 0.01% |
+60,000
| New | +$2.82M |
|
|
VRNA
750
Verona Pharma
VRNA
$9.17B
| $2.82M | 0.01% |
175,000
-476,931
| -73% | -$7.67M |
|